Labcorp and its Specialty Testing Group, a fully integrated portfolio of specialty and esoteric testing laboratories.

PD-L1 Testing

Order PD-L1 Testing

If you have an Integrated Oncology account, order PD-L1 Testing by completing the on-line Prognostic/Therapeutic  requisition, save to desktop and print.

If not a current client, contact Integrated Oncology to set up an account and to order a test.

Immune Checkpoint Inhibitors

Overexpression of PD-L1 has been observed in many carcinomas including lung, urothelial, gastroesphageal junction, Squamous Cell Carcinoma of the Head and Neck (SCCHN), cervical, triple-negative breast cancer (TNBC) and melanoma

Tumor PD-L1 expression levels have been shown to be a predictive marker with response to several anti-PD1 antibodies1,2


Please see the test menu for additional specimen and test information.